01
RESEARCHMayo Clinic
Mayo AI detects pancreatic cancer 3 years before clinical diagnosisSummary
Mayo Clinic validated an AI model that identifies pancreatic cancer up to three years before standard clinical diagnosis. The validation study represents a potential shift in screening protocols for high-risk patient populations.
Our take
Pancreatic cancer's 5% five-year survival rate makes early detection the primary clinical lever for outcomes. Single source — verify before acting.
What this means for practitioners
Chief medical officers and oncology department heads should evaluate this for high-risk screening protocols. Contact Mayo's AI team within 7 days to understand validation methodology and potential licensing terms.